Premium
O3–06–01: A clinical phase II study of Lu AE58054 added to stable donepezil treatment in patients with moderate Alzheimer's disease
Author(s) -
Wilkinson David,
ColdingJørgensen Eskild,
Windfeld Kristian
Publication year - 2013
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.04.267
Subject(s) - tolerability , donepezil , medicine , placebo , clinical endpoint , dementia , clinical trial , confidence interval , adverse effect , disease , alternative medicine , pathology